Fig. 5From: A nomogram based on peripheral lymphocyte for predicting 8-year survival in patients with prostate cancer: a single-center study using LASSO-cox regressionDecision curve analyses with clinical net benefits of the nomogram at 5 year (A), 8 year (B) and 10 year (C)Back to article page